Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA.

Moreno-Mayordomo R, Ruiz M, Pascual J, Gallego de la Sacristana M, Vidriales I, Sobrado M, Cernuda-Morollon E, Gago-Veiga AB, Garcia-Azorin D, Telleria JJ, Guerrero AL.

J Headache Pain. 2019 Apr 23;20(1):39. doi: 10.1186/s10194-019-0989-9.

2.

Characterization of Plasma-Derived Extracellular Vesicles Isolated by Different Methods: A Comparison Study.

Serrano-Pertierra E, Oliveira-Rodríguez M, Rivas M, Oliva P, Villafani J, Navarro A, Blanco-López MC, Cernuda-Morollón E.

Bioengineering (Basel). 2019 Jan 17;6(1). pii: E8. doi: 10.3390/bioengineering6010008.

3.

Neuropeptides as a Marker for Chronic Headache.

Riesco N, Cernuda-Morollón E, Pascual J.

Curr Pain Headache Rep. 2017 Apr;21(4):18. doi: 10.1007/s11916-017-0618-8. Review.

PMID:
28281109
4.

Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine.

Ramón C, Cernuda-Morollón E, Pascual J.

Curr Opin Neurol. 2017 Jun;30(3):281-286. doi: 10.1097/WCO.0000000000000440. Review.

PMID:
28234796
5.

No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.

Cernuda-Morollón E, Riesco N, Martínez-Camblor P, Serrano-Pertierra E, García-Cabo C, Pascual J.

Headache. 2016 Oct;56(9):1448-1454. doi: 10.1111/head.12949. Epub 2016 Sep 16.

PMID:
27634731
6.

Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids.

Oliveira-Rodríguez M, López-Cobo S, Reyburn HT, Costa-García A, López-Martín S, Yáñez-Mó M, Cernuda-Morollón E, Paschen A, Valés-Gómez M, Blanco-López MC.

J Extracell Vesicles. 2016 Aug 12;5:31803. doi: 10.3402/jev.v5.31803. eCollection 2016.

7.

Point-of-care detection of extracellular vesicles: Sensitivity optimization and multiple-target detection.

Oliveira-Rodríguez M, Serrano-Pertierra E, García AC, López-Martín S, Yañez-Mo M, Cernuda-Morollón E, Blanco-López MC.

Biosens Bioelectron. 2017 Jan 15;87:38-45. doi: 10.1016/j.bios.2016.08.001. Epub 2016 Aug 2.

PMID:
27517736
8.

Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients.

Riesco N, Cernuda-Morollón E, Martínez-Camblor P, Pérez-Alvarez AI, Verano L, García-Cabo C, Serrano-Pertierra E, Pascual J.

Cephalalgia. 2017 Aug;37(9):823-827. doi: 10.1177/0333102416653232. Epub 2016 Jun 1.

PMID:
27250233
9.

RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border.

Marcos-Ramiro B, García-Weber D, Barroso S, Feito J, Ortega MC, Cernuda-Morollón E, Reglero-Real N, Fernández-Martín L, Durán MC, Alonso MA, Correas I, Cox S, Ridley AJ, Millán J.

J Cell Biol. 2016 May 9;213(3):385-402. doi: 10.1083/jcb.201504038. Epub 2016 May 2.

10.

[Arterial pathology in migraine: endothelial dysfunction and structural changes in the brain and systemic vasculature].

Larrosa-Campo D, Ramón-Carbajo C, Álvarez-Escudero R, Cernuda-Morollón E, García-Cabo C, Pascual J.

Rev Neurol. 2015 Oct 1;61(7):313-22. Review. Spanish.

11.

Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: Usefulness of a new scale.

Riesco N, Pérez-Alvarez AI, Verano L, García-Cabo C, Martínez-Ramos J, Sánchez-Lozano P, Cernuda-Morollón E, Pascual J.

Cephalalgia. 2016 Apr;36(4):346-50. doi: 10.1177/0333102415593087. Epub 2015 Jun 25.

PMID:
26111946
12.

Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis.

Serrano-Pertierra E, Blanco-Gelaz MA, Oliva-Nacarino P, Martínez-Camblor P, Villafani J, López-Larrea C, Cernuda-Morollón E.

J Neuroimmunol. 2015 May 15;282:39-44. doi: 10.1016/j.jneuroim.2015.03.007. Epub 2015 Mar 7.

PMID:
25903727
13.

OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine.

Cernuda-Morollón E, Ramón C, Martínez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J.

Pain. 2015 May;156(5):820-4. doi: 10.1097/j.pain.0000000000000119.

PMID:
25735000
14.

Long-term experience with onabotulinumtoxinA in the treatment of chronic migraine: What happens after one year?

Cernuda-Morollón E, Ramón C, Larrosa D, Alvarez R, Riesco N, Pascual J.

Cephalalgia. 2015 Sep;35(10):864-8. doi: 10.1177/0333102414561873. Epub 2014 Nov 27.

PMID:
25431141
15.

Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.

Marcos-Ramiro B, Oliva Nacarino P, Serrano-Pertierra E, Blanco-Gelaz MA, Weksler BB, Romero IA, Couraud PO, Tuñón A, López-Larrea C, Millán J, Cernuda-Morollón E.

BMC Neurosci. 2014 Sep 22;15:110. doi: 10.1186/1471-2202-15-110.

16.

Apicobasal polarity controls lymphocyte adhesion to hepatic epithelial cells.

Reglero-Real N, Álvarez-Varela A, Cernuda-Morollón E, Feito J, Marcos-Ramiro B, Fernández-Martín L, Gómez-Lechón MJ, Muntané J, Sandoval P, Majano PL, Correas I, Alonso MA, Millán J.

Cell Rep. 2014 Sep 25;8(6):1879-1893. doi: 10.1016/j.celrep.2014.08.007. Epub 2014 Sep 18.

17.

Receiver operating characteristic curve generalization for non-monotone relationships.

Martínez-Camblor P, Corral N, Rey C, Pascual J, Cernuda-Morollón E.

Stat Methods Med Res. 2017 Feb;26(1):113-123. doi: 10.1177/0962280214541095. Epub 2016 Jul 11.

PMID:
24986857
18.

Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.

Cernuda-Morollón E, Martínez-Camblor P, Alvarez R, Larrosa D, Ramón C, Pascual J.

Cephalalgia. 2015 Apr;35(4):310-6. doi: 10.1177/0333102414535111. Epub 2014 May 20.

PMID:
24847167
19.

L-plastin is involved in NKG2D recruitment into lipid rafts and NKG2D-mediated NK cell migration.

Serrano-Pertierra E, Cernuda-Morollón E, Brdička T, Hoøejši V, López-Larrea C.

J Leukoc Biol. 2014 Sep;96(3):437-45. doi: 10.1189/jlb.2A1013-564R. Epub 2014 May 6.

20.

CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.

Cernuda-Morollón E, Martínez-Camblor P, Ramón C, Larrosa D, Serrano-Pertierra E, Pascual J.

Headache. 2014 Jun;54(6):987-95. doi: 10.1111/head.12372. Epub 2014 May 6.

PMID:
24673487
21.

[Something's moving in chronic migraine].

Cernuda-Morollón E, Pascual J.

Rev Neurol. 2014 Jan 1;58(1):1-3. Spanish.

22.

Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions.

Santamarta E, Meilán A, Saiz A, Larrosa D, Cernuda-Morollón E, Calleja S, Benavente L, Morís G, Pascual J.

J Neurol Sci. 2014 Jan 15;336(1-2):180-3. doi: 10.1016/j.jns.2013.10.035. Epub 2013 Oct 29.

PMID:
24211062
23.

NKG2D- and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASp.

Serrano-Pertierra E, Cernuda-Morollón E, López-Larrea C.

J Leukoc Biol. 2014 Mar;95(3):487-95. doi: 10.1189/jlb.0613316. Epub 2013 Oct 29.

PMID:
24168855
24.

Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.

Cernuda-Morollón E, Larrosa D, Ramón C, Vega J, Martínez-Camblor P, Pascual J.

Neurology. 2013 Oct 1;81(14):1191-6. doi: 10.1212/WNL.0b013e3182a6cb72. Epub 2013 Aug 23.

PMID:
23975872
25.

[Migraine as a vascular risk factor].

Larrosa-Campo D, Ramón-Carbajo C, Para-Prieto M, Calleja-Puerta S, Cernuda-Morollón E, Pascual J.

Rev Neurol. 2012 Sep 16;55(6):349-58. Review. Spanish.

26.

Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function.

Fernández-Martín L, Marcos-Ramiro B, Bigarella CL, Graupera M, Cain RJ, Reglero-Real N, Jiménez A, Cernuda-Morollón E, Correas I, Cox S, Ridley AJ, Millán J.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):e90-102. doi: 10.1161/ATVBAHA.112.252080. Epub 2012 Jun 21.

PMID:
22723439
27.

Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.

Serrano-Pertierra E, Cernuda-Morollón E, López-Larrea C.

Eur J Immunol. 2012 Aug;42(8):2142-51. doi: 10.1002/eji.201142070.

28.

Rac activation by the T-cell receptor inhibits T cell migration.

Cernuda-Morollón E, Millán J, Shipman M, Marelli-Berg FM, Ridley AJ.

PLoS One. 2010 Aug 25;5(8):e12393. doi: 10.1371/journal.pone.0012393.

29.

Discriminating between the paracellular and transcellular routes of diapedesis.

Cernuda-Morollón E, Gharbi S, Millán J.

Methods Mol Biol. 2010;616:69-82. doi: 10.1007/978-1-60761-461-6_5.

PMID:
20379869
30.

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

Garín MI, Chu CC, Golshayan D, Cernuda-Morollón E, Wait R, Lechler RI.

Blood. 2007 Mar 1;109(5):2058-65. Epub 2006 Nov 16.

31.

Differential effects of immunosuppressive drugs on T-cell motility.

Datta A, David R, Glennie S, Scott D, Cernuda-Morollon E, Lechler RI, Ridley AJ, Marelli-Berg FM.

Am J Transplant. 2006 Dec;6(12):2871-83.

32.

Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells.

Cernuda-Morollón E, Ridley AJ.

Circ Res. 2006 Mar 31;98(6):757-67. Review.

PMID:
16574916
33.

Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.

Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D.

Mol Pharmacol. 2004 Nov;66(5):1349-58. Epub 2004 Aug 18.

PMID:
15317873
34.

Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.

Pérez-Sala D, Cernuda-Morollón E, Cañada FJ.

J Biol Chem. 2003 Dec 19;278(51):51251-60. Epub 2003 Oct 7.

35.

Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins.

Pérez-Sala D, Cernuda-Morollón E, Pineda-Molina E, Cañada FJ.

Ann N Y Acad Sci. 2002 Nov;973:533-6.

PMID:
12485923
36.

Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway.

Stamatakis K, Cernuda-Morollón E, Hernández-Perera O, Pérez-Sala D.

J Biol Chem. 2002 Dec 20;277(51):49389-96. Epub 2002 Oct 15.

37.

PPAR agonists amplify iNOS expression while inhibiting NF-kappaB: implications for mesangial cell activation by cytokines.

Cernuda-Morollón E, Rodríguez-Pascual F, Klatt P, Lamas S, Pérez-Sala D.

J Am Soc Nephrol. 2002 Sep;13(9):2223-31.

38.

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.

Cernuda-Morollón E, Pineda-Molina E, Cañada FJ, Pérez-Sala D.

J Biol Chem. 2001 Sep 21;276(38):35530-6. Epub 2001 Jul 20.

39.

Posttranscriptional regulation of human iNOS by the NO/cGMP pathway.

Pérez-Sala D, Cernuda-Morollón E, Díaz-Cazorla M, Rodríguez-Pascual F, Lamas S.

Am J Physiol Renal Physiol. 2001 Mar;280(3):F466-73.

Supplemental Content

Loading ...
Support Center